Cargando…
AS-605240 Blunts Osteoporosis by Inhibition of Bone Resorption
BACKGROUND: Osteoporosis is a metabolic bone disease. Osteoclasts are significantly involved in the pathogenesis of osteoporosis. AS-605240 (AS) is a small molecule PI3K-γ inhibitor and is less toxic compared to pan-PI3K inhibitors. AS also exerts multiple biological effects including anti-inflammat...
Autores principales: | Sun, Jiacheng, Cai, Guoping, Shen, Jinlong, Cheng, Pu, Zhang, Jiapeng, Jiang, Dengteng, Xu, Xianquan, Lu, Fangying, Chen, Lihua, Chen, Haixiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150757/ https://www.ncbi.nlm.nih.gov/pubmed/37138583 http://dx.doi.org/10.2147/DDDT.S403231 |
Ejemplares similares
-
Isoliquiritigenin blunts osteoarthritis by inhibition of bone resorption and angiogenesis in subchondral bone
por: Ji, Baochao, et al.
Publicado: (2018) -
The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes
por: Azzi, Jamil, et al.
Publicado: (2012) -
The Dibenzyl Isoquinoline Alkaloid Berbamine Ameliorates Osteoporosis by Inhibiting Bone Resorption
por: Zhang, Chongjing, et al.
Publicado: (2022) -
Phosphoinositide 3-kinase inhibitor AS605240 ameliorates streptozotocin-induced Alzheimer’s disease like sporadic dementia in experimental rats
por: Alluri, Ramesh, et al.
Publicado: (2020) -
Modulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2015)